Antimicrobial Resistance of Bacteria in Burn Patients

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Texas Tech University Health Sciences Center Identifier:
First received: November 19, 2008
Last updated: January 6, 2014
Last verified: January 2014

The purpose of this study is to test the resistance of pathogenic bacteria in infected tissues of burn patients to various antimicrobials and enzyme debriders.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Analyzing the Antimicrobial Resistance Profile of Bacterial Isolates Obtained From Severely Burned Patients

Resource links provided by NLM:

Further study details as provided by Texas Tech University Health Sciences Center:

Primary Outcome Measures:
  • Types of bacteria [ Time Frame: 28 days ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Bacterial isolates of infected burn wounds

Enrollment: 32
Study Start Date: November 2008
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Burn Wounds
Patients with burn wounds

Detailed Description:

Bacteria that is present in infected burn wounds will be isolated and identified. The isolates will be tested for resistance to commercially available antimicrobials.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with open,unhealed,burn wounds


Inclusion Criteria:

  • Males and females of any age
  • Have open, unhealed wounds(s) that will be cultured per standard of care
  • Subject or authorized representative provide informed consent

Exclusion Criteria:

  • Informed consent not provided or able to be obtained
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00794742

United States, Texas
University Medical Center
Lubbock, Texas, United States, 79415
Sponsors and Collaborators
Texas Tech University Health Sciences Center
Principal Investigator: John Griswold, M.D. Texas Tech University Health Sciences Center
  More Information

No publications provided

Responsible Party: Texas Tech University Health Sciences Center Identifier: NCT00794742     History of Changes
Other Study ID Numbers: TTUHSC-L09-014
Study First Received: November 19, 2008
Last Updated: January 6, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Texas Tech University Health Sciences Center:

Additional relevant MeSH terms:
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses processed this record on March 26, 2015